False positive rates for the Mcm5 and NMP22 tests across benign conditions.

For each subgroup, only those patients with a test results were considered.Abbreviations: BPH, benign prostatic hyperplasia; FPR, false positive rate; IQR, interquartile range; med, median; UTI, urinary tract infection.aMann-Whitney test, comparison of test value with normal.bFalse positive rate determined using 2150-cell cut-point for Mcm5 test and 10 U/mL cut-point for NMP22 test.cChi-squared test, comparison of false positive rate with Normal group.dExcludes 53 “other cancers” of the 1354 patients without UCC having an Mcm5 test value.eExcludes 47 “other cancers” of the 1201 patients without UCC having an NMP22 test value.